Sun and Taro mutually terminate the unsolicited acquisition offer from Sun to acquire the 33.8% of the Taro it does not already own

Taro Pharmaceutical Industries Ltd.

Israel / Mid-Cap Biopharma ($1-$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sun Pharmaceutical Industries Ltd.

India / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled